LIFRα-CT3 induces differentiation of a human acute myelogenous leukemia cell line HL-60 by suppressing miR-155 expression through the JAK/STAT Pathway

被引:14
作者
Xu, Sha [1 ]
Xu, Zhenyu [1 ]
Liu, Baohai [3 ]
Sun, Qing [1 ]
Yang, Ling [1 ]
Wang, Jianmin [2 ]
Wang, Yue [1 ]
Liu, Houqi [1 ]
机构
[1] Second Mil Med Univ, Dept Embryol & Histol, Shanghai 200433, Peoples R China
[2] Changhai Hosp Shanghai, Dept Hematol, Shanghai, Peoples R China
[3] Second Mil Med Univ, Grad Sch, Shanghai, Peoples R China
关键词
Acute myeloid leukemia; MicroRNA-155; Leukemia inhibitory factor; LIF receptor; Protein transduction; STAT3; ACUTE MYELOID-LEUKEMIA; DISTAL CYTOPLASMIC MOTIFS; STEM-CELLS; STAT3; ALPHA; PROLIFERATION; INTERLEUKIN-6; INHIBITION; INDUCTION; MICRORNAS;
D O I
10.1016/j.leukres.2014.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The distal cytoplasmic motifs of the leukemia inhibitory factor receptor alpha-chain (LIFR alpha-CT3) and its TAT fusion protein (TAT-CT3) can independently suppress cell viability and induce myeloid differentiation inhuman leukemia HL-60 cells in our previous studies. But its underlying mechanism remains undefined. Herein, we show that a prokaryotic expressed TAT-CT3 induced a rapid elevation of STAT3 phosphorylation (pSTAT3), and then suppress the transcription of miR-155 and induce the elevation of SOCS-1, which further inhibited STAT3 phosphorylation for a long-term period. Our result indicated a novel mechanism of TAT-CT3 to promote HL60 cells differentiation, which provides some potential therapeutic targets for future acute myelogenous leukemia therapy. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1237 / 1244
页数:8
相关论文
共 21 条
  • [1] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [2] Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
    Epling-Burnette, PK
    Liu, JH
    Catlett-Falcone, R
    Turkson, J
    Oshiro, M
    Kothapalli, R
    Li, YX
    Wang, JM
    Yang-Yen, HF
    Karras, J
    Jove, R
    Loughran, TP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) : 351 - 361
  • [3] MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
    Garzon, Ramiro
    Volinia, Stefano
    Liu, Chang-Gong
    Fernandez-Cymering, Cecilia
    Palumbo, Tiziana
    Pichiorri, Flavia
    Fabbri, Muller
    Coombes, Kevin
    Alder, Hansjuerg
    Nakamura, Tatsuya
    Flomenberg, Neal
    Marcucci, Guido
    Calin, George A.
    Kornblau, Steven M.
    Kantarjian, Hagop
    Bloomfield, Clara D.
    Andreeff, Michael
    Croce, Carlo M.
    [J]. BLOOD, 2008, 111 (06) : 3183 - 3189
  • [4] Guo SY, 2007, BRAZ J MED BIOL RES, V40, P621, DOI 10.1590/S0100-879X2007000500004
  • [5] Hu HM, 1998, J IMMUNOL, V160, P2334
  • [6] MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
    Jongen-Lavrencic, Mojca
    Sun, Su Ming
    Dijkstra, Menno K.
    Valk, Peter J. M.
    Lowenberg, Bob
    [J]. BLOOD, 2008, 111 (10) : 5078 - 5085
  • [7] Identification of tissue-specific microRNAs from mouse
    Lagos-Quintana, M
    Rauhut, R
    Yalcin, A
    Meyer, J
    Lendeckel, W
    Tuschl, T
    [J]. CURRENT BIOLOGY, 2002, 12 (09) : 735 - 739
  • [8] STAT3: A multifaceted oncogene
    Levy, David E.
    Inghirami, Giorgio
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (27) : 10151 - 10152
  • [9] The prognostic and functional role of microRNAs in acute myeloid leukemia
    Marcucci, Guido
    Mrozek, Krzysztof
    Radmacher, Michael D.
    Garzon, Ramiro
    Bloomfield, Clara D.
    [J]. BLOOD, 2011, 117 (04) : 1121 - 1129
  • [10] IL-10 Inhibits miR-155 Induction by Toll-like Receptors
    McCoy, Claire E.
    Sheedy, Frederick J.
    Qualls, Joseph E.
    Doyle, Sarah L.
    Quinn, Susan R.
    Murray, Peter J.
    O'Neill, Luke A. J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (27) : 20492 - 20498